췌장암에 대한 국내 한의학 연구 동향 고찰 - 국내 한의학 논문을 중심으로 -

키워드

참고문헌 (85)

1. Siegel R, "Cancer statistics, 2012", CA Cancer J Clin, 62, pp.10~29 (2012)
2. "National Center Information Cancer" (2019)[URL]
3. "American cancer society" (2019)[URL]
4. "Plymouth Meeting" (2019)[URL]
5. 방승민, "췌장암의 감시와 조기 진단", 대한췌담도학회지, 20(1), pp.1~4 (2015), 대한췌장담도학회[DOI]
6. 김재우, "췌장암의 최신치료", 대한내과학회지, 77(6), pp.695~702 (2009), 대한내과학회
7. 류지곤, "절제 불가능한 췌장암 항암치료의 최신 지견", 대한소화기학회지, 66(3), pp.150~153 (2015), 대한소화기학회
8. Park JG, "Oncology", pp.317~318 (2012), Iljogak
9. 방승민, "전이성 췌장암의 새로운 치료법", 대한췌담도학회지, 21(4), pp.185~190 (2016), 대한췌장담도학회[DOI]
10. Lee BM, "A Case of Near Complete Response in Metastatic Pancreatic Cancer after Gemcitabine Chemotherapy", Korean J Pancreas and Biliary Tract, 18(1), pp.46~50 (2013)
11. Jang SO, "Gemcitabine plus Capecitabine versus Gemcitabine Alone as First-line Therapy for Patients with Advanced or Metastatic Pancreatic Cancer :Efficacy and Economic Evaluation", master's, pp.2010
12. Schmitz KH, "American College of Sports Medicine roundtable on exercise guidelines for cancer survivors", Med Sci Sports Exerc, 42(7), pp.1409~1426 (2010)
13. Shapiro CL, "Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer", J Clin Oncol, 19(14), pp.3306~3310 (2001)
14. Li M, "Different Survival Benefits of Chinese Medicine for Pancreatic Cancer:How to Choose?", Chin J Integr Med, 24(3), pp.178~184 (2018)
15. Levy MH, "Palliative care", J Natl Compr Canc Netw, 10(10), pp.1284~1309 (2012)
16. Smith TJ, "American Society of Clinical Oncology Provisional Clinical Opinion : the integration of palliative care into standard oncology care", J Clin Oncol, 30(8), pp.880~887 (2012)
17. Li B, "Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer : A Systematic Review and Meta-Analysis", Evid Based Complement Alternat Med, 2015, pp.350730~ (2015)
18. 한가진, "유방암에 대한 국내 한의학 연구 동향 고찰- 국내 한의학 논문을 중심으로 -", 대한한방내과학회지, 39(1), pp.44~68 (2018), 대한한방내과학회
19. 한가진, "Systematic Review of Case Reports about Korean Medicine for Lung Cancer", 대한한의학회지, 39(4), pp.136~157 (2018), 대한한의학회[DOI]
20. 강윤환, "대장암 환자의 한약 및 침치료에 대한 국내외 임상연구 결과에 대한 고찰 – Pubmed를 중심으로", 동의생리병리학회지, 30(4), pp.219~228 (2016), 한의병리학회[DOI]
21. 이지은, "항암제와 한약재의 병용투여 시 암세포 증식억제 효과에 대한 국내 실험연구 문헌고찰", 대한한의학 방제학회지, 25(3), pp.391~412 (2017), 대한한의학방제학회[DOI]
22. 김종한, "국내 한의학 암치료 임상연구 논문에 대한 고찰", Journal of Acupuncture Research, 29(3), pp.19~28 (2012), 대한침구의학회[DOI]
23. 최철민, "간, 담도, 췌장의 진행암으로 한방병원에 내원한 환자의 삶의 질(FACT-G)에 대한 분석", 대한한의학회지, 29(4), pp.30~38 (2008), 대한한의학회
24. 김경수, "Allergen 제거한 Rhus Verniciflua Stokes의 원격전이된 췌장암에 대한 연구", 석사, 사상체질, pp.2010
25. Kang HJ, "Alterations and Correlations Analysis of Natural Killer Cell Activity and Systemic Inflammatory Markers for Gastric, Breast and Pancreatic Cancer Patients Treated with Wheel Balance Cancer Therapy", pp.2016
26. 박상은, "藥鍼療法을 통한 췌장암환자의 喘證 治險 1例", Journal of Pharmacopuncture, 9(1), pp.59~67 (2006), 대한약침학회
27. 방선휘, "림프절 전이를 동반한 췌장암환자 1례에 대한 보고", 대한한방내과학회지, 28(4), pp.948~955 (2007), 대한한방내과학회
28. Yoon HY, "A Case Report of Unresectable Pancreatic Carcinoma Patient for Relieving Cancer Related Pain and Improving Quality of Life by Korean Medical Treatment", J of Kor Traditional Oncology, 18(1), pp.9~15 (2013)
29. 서상훈, "췌장전이를 동반한 담도암환자 1례에 대한 보고", 대한한방내과학회지, 23(4), pp.735~740 (2002), 대한한방내과학회
30. Kim JM, "Case Report of the Pancreatic Cancer Patient after Pancreatoduodenectomy who is Taking the HangAm-Plus to Anti-metastasis and Preventing Recurrence", J of Kor Traditional Oncology, 16(1), pp.33~39 (2011)
31. Park DW, "Pancreatic cancer", J of East-West Med, 5(1), pp.51~53 (1980)
32. Park SJ, "Preliminary Study for Development of Korean Medicine Clinical Practice Guideline for Pancreatic Cancer", J of Kor Traditional Oncology, 22(1), pp.1~11 (2017)
33. 이종호, "암 휴면 치료의 체계적 고찰 : 한약을 이용한 암치료를 중심으로", 석사, 한의학과 한방내과학전공, pp.2012
34. 김훈, "扶正抗癌湯의 사람 췌장암 세포주 PANC-1에 대한 抗腫瘍 效果", 대한한의학 방제학회지, 15(1), pp.213~228 (2007), 대한한의학방제학회
35. 백동기, "팔진항암단이 췌장암 세포주 PANC-1의 세포주기 억제와 세포고사에 미치는 영향", 박사, 한의학, pp.2008
36. Kang BH, "Effect of Herbal Mixture Extract (H3) on Cancer Stem Cells and Apoptosis of Pancreatic Cancer Cell Line", master's, pp.2015
37. 강용경, "췌장암 세포주에 대한 꾸지뽕잎 추출물의 세포독성 효과", 대한암예방학회지, 16(4), pp.333~339 (2011), 대한암예방학회
38. Hong JY, "Anticancer Properties of Astilbe rubra Extracts on AsPC-1 Human Pancreatic Cancer Cells", J of basic science, 32, pp.21~28 (2015)
39. 이인영, "췌장암 세포주 MIA PaCa-2에서 황백 물 추출물에 의한 Apoptosis 유도 및 작용기전", 동의생리병리학회지, 27(2), pp.202~211 (2013), 한의병리학회
40. 김성중, "몰약이 췌장암세포에 미치는 효과", 석사, 한의학과, pp.2013
41. 주현아, "인진과 황련 추출물의 췌장암 세포주 MIA PaCa-2에 대한세포사멸 효과", 한방안이비인후피부과학회지, 27(4), pp.158~176 (2014), 대한한방안이비인후피부과학회
42. Lee C, "Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis", Med Oncol, 30(4), pp.700~ (2013)
43. Ryan DP, "Pancreatic adenocarcinoma", NEJM, 371(11), pp.1039~1049 (2014)
44. 이남헌, "암의 종류 및 증상에 따른 삶의 질 평가 척도에 관한 연구 현황 분석", 대한한방내과학회지, 27(3), pp.555~560 (2006), 대한한방내과학회
45. 이은현, "암 환자 삶의 질에 대한 국내 연구논문 분석", Radiation oncology journal, 20(4), pp.359~366 (2002), 대한방사선종양학회
46. Cho CK, "Wheel Balance Cancer Therapy :Patient-centered balance therapy to inhibit metastasis and recurrence", pp.14~15 (2015), Dajeong Books
47. Yoo HS, "Review of the best case series methodology : best case series results of East-West Cancer Center", Integr Cancer Ther, 7(3), pp.182~188 (2008)
48. Park HM, "Integrative Tumor Board : A Case Report and Discussion From East-West Cancer Center", Integrative Cancer Therapies, 9(2), pp.236~245 (2010)
49. Jeong-seok Park, "Wheel Balance Cancer Therapy in the Treatment of Metastatic Gastric Carcinoma : A Retrospective Analysis of 62 Patients", 대한한방내과학회지, 28(3), pp.531~543 (2007), 대한한방내과학회
50. Zheng HM, "Evidence based approach of wheel balance cancer therapy;A Review", J of Kor Traditional Oncology, 17(2), pp.1~16 (2012)
51. Kitts DD, "Antitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes", J Toxicol Environ Health A, 64(4), pp.357~371 (2001)
52. Kim JH, "Inhibition of the PI3K-Akt", PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines, 2008, pp.265(2), 197~205
53. Lee JH, "Rhus verniciflua Stokes prevents cisplatin-induced cytotoxicity and reactive oxygen species production in MDCK-I renal cells and intact mice", Phytomedicine, 16(2-3), pp.188~197 (2009)
54. Kim JH, "Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua Stokes", Am J Chin Med, 37(3), pp.609~620 (2009)
55. 김경순, "항암단 투여로 호전된 진행성 또는 전이성 담낭암 연속환자증례", 대한한방내과학회지, 31(3), pp.667~674 (2010), 대한한방내과학회
56. 이동은, "항암단 및 그 주요 성분의 Calu6 와 MCF-7 사람 암세포주에 대한 항암효과", 대한한의학회지, 30(5), pp.50~60 (2009), 대한한의학회
57. 유화승, "Two Cases of Endometrial Cancer Treated with Palliative Herbal Medication Hangam-dan (HAD)", 대한한의학회지, 28(4), pp.176~180 (2007), 대한한의학회
58. 방지영, "Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B), a Korean traditional medicine, using antibody microarray chip", BioChip Journal, 4(4), pp.350~355 (2010), 한국바이오칩학회
59. 유화승, "A Toxicological Study of HangAmDan-B in Mice", Journal of Acupuncture & Meridian Studies, 4(1), pp.54~60 (2011), 사단법인약침학회
60. Wong GY, "Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer : a randomized controlled trial", JAMA, 291(9), pp.1092~1099 (2004)
61. Nie J, "Efficacy of traditional Chinese medicine in treating cancer", Biomedical reports, 4(1), pp.3~14 (2016)
62. Saif MW, "Is there a role for herbal medicine in the treatment of pancreatic cancer?", Jop, 9(4), pp.403~407 (2008)
63. Cho CK, "Cancer Dormancy Therapy Asan", pp.15~31 (2005), Dajeong Books
64. "American Type Culture Collection" (2019)[URL]
65. "American Type Culture Collection" (2019)[URL]
66. "American Type Culture Collection" (2019)[URL]
67. Hanahan D, "Hallmarks of cancer : the next generation", Cell, 144(5), pp.646~674 (2011)
68. Yin H, "Free radical oxidation of cardiolipin : chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases", Free Radic Res, 46(8), pp.959~974 (2012)
69. Elmore S, "Apoptosis : a review of programmed cell death", Toxicol Pathol, 35(4), pp.495~516 (2007)
70. Miyashita T, "Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo", Oncogene, 9(6), pp.1799~1805 (1994)
71. Li P, "Caspase-9 : structure, mechanisms and clinical application", Oncotarget, 8(14), pp.23996~24008 (2017)
72. Hiraoka D, "Two new competing pathways establish the threshold for cyclin-B–Cdk1 activation at the meiotic G2", M transition, 2016, pp.129(16), 3153~3166
73. Petak I, "Shared pathways : death receptors and cytotoxic drugs in cancer therapy", Pathol Oncol Res, 7(2), pp.95~106 (2001)
74. Yadav N, "Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents", Cell Death Dis, 6, pp.e1969~ (2015)
75. Kim BJ, "Experimental study about the Anti-tumor Effects of Bujeonghangamtang", master's, pp.1997
76. Leem MR, "The Effects of Bujeonghangamtang on antitumor Immune Response", J Korean Oriental Med, 19(1), pp.234~250 (1998)
77. 이건업, "八珍抗癌丹의 인간 前骨髓性 白血病 세포 사멸 효과", 동의생리병리학회지, 16(3), pp.16~520 (2002), 한의병리학회
78. Baek DG, "Anticancer effect of Paljinhangahm-dan in Human Acute Myeloid Leukemia", master's, pp.2002
79. 백은기, "인간 간암세포주 HepG2에서 八珍抗癌丹과 adriamycin의 병용처리에 의한 抗腫瘍 효과", 동의생리병리학회지, 17(5), pp.1243~1250 (2003), 한의병리학회
80. Iizuka N, "Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines", Cancer Lett, 148(1), pp.19~25 (2000)
81. Zhou H, "The effect of berberine chloride on experimental colitis in rats in vivo and in vitro", J Pharmacol Exp Ther, 294(3), pp.822~829 (2000)
82. Lee MJ, "Antioxidant and Nitrite Scavenging Activity of Water-Extract from Phellodendron amurense Rupr", J Physiol &Pathol Korean Med, 13(1), pp.112~119 (1999)
83. 金義根, "黃柏의 腫瘍抑制 및 免疫活性에 관한 硏究", 대한한방부인과학회지, 15(1), pp.19~30 (2002), 대한한방부인과학회
84. 박종규, "沒藥이 子宮頸部癌細胞(HeLa Cell)의 Apoptosis에 미치는 影響", 대한한방부인과학회지, 19(1), pp.97~110 (2006), 대한한방부인과학회
85. Kang DI, "Study on the inhibitory Effect of Molyaksan(沒藥散)on Angiogenesis", Korean J of Orienrtal Physiology &Pathology, 14(2), pp.91~107 (2000)

관련 논문AI추천